L-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes

L-Alpha-glycerylphosphorylcholine (GPC) is a widely used food supplement. GPC has been shown to exert beneficial effects in several organs; however, the cardiac effects of GPC have yet to be investigated. The aim of the present study was therefore to map out the effects of GPC on cardiac myocytes, w...

Full description

Saved in:
Bibliographic Details
Main Authors: Tuboly Eszter
Gáspár Renáta
Olias Ibor Miguel
Gömöri Kamilla
Kiss Bernadett
Strifer Gerda
Hartmann Petra
Ferdinandy Péter
Bartekova Monika
Boros Mihály
Görbe Anikó
Format: Article
Published: 2019
Series:MOLECULAR AND CELLULAR BIOCHEMISTRY 460 No. 1-2
doi:10.1007/s11010-019-03580-1

mtmt:30733384
Online Access:http://publicatio.bibl.u-szeged.hu/16845
LEADER 02756nab a2200325 i 4500
001 publ16845
005 20190925133615.0
008 190925s2019 hu o 0|| zxx d
022 |a 0300-8177 
024 7 |a 10.1007/s11010-019-03580-1  |2 doi 
024 7 |a 30733384  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Tuboly Eszter 
245 1 0 |a L-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes  |h [elektronikus dokumentum] /  |c  Tuboly Eszter 
260 |c 2019 
300 |a 195-203 
490 0 |a MOLECULAR AND CELLULAR BIOCHEMISTRY  |v 460 No. 1-2 
520 3 |a L-Alpha-glycerylphosphorylcholine (GPC) is a widely used food supplement. GPC has been shown to exert beneficial effects in several organs; however, the cardiac effects of GPC have yet to be investigated. The aim of the present study was therefore to map out the effects of GPC on cardiac myocytes, with or without ischemia-reperfusion insult. Neonatal rat cardiac myocytes were treated with GPC at 1, 10, 80, and 100 µM concentrations for 15 min, 3 h, or 24 h, respectively. Cell viability by calcein assay and the degree of oxidative stress by DHE (superoxide level) and H2DCF (total ROS accumulation) staining were measured. In separate experiments, cardiomyocytes were pre-treated with the optimal concentration of GPC for 3 h and then cells were exposed to 4 h of simulated ischemia followed by 2 h of reperfusion (SI/R). Cell viability was measured at the end of the SI/R protocol. In normoxic conditions, the 15-min and the 3-h GPC treatment did not affect cell viability, total ROS, and superoxide levels. Under SI/R conditions, the 3-h GPC treatment protected the cardiac myocytes from SI/R-induced cell death and did not alter the level of oxidative stress. The 24-h GPC treatment in normoxic conditions resulted in significant cell death and increased oxidative stress at each concentration. Here we provide the first evidence for the cytoprotective effect of short-term GPC treatment. However, long-term administration of GPC may exert cytotoxicity in a wide concentration range in cardiac myocytes. These results may draw attention to a comprehensive cardiac safety protocol for the testing of GPC. 
700 0 1 |a Gáspár Renáta  |e aut 
700 0 1 |a Olias Ibor Miguel  |e aut 
700 0 1 |a Gömöri Kamilla  |e aut 
700 0 1 |a Kiss Bernadett  |e aut 
700 0 1 |a Strifer Gerda  |e aut 
700 0 1 |a Hartmann Petra  |e aut 
700 0 1 |a Ferdinandy Péter  |e aut 
700 0 1 |a Bartekova Monika  |e aut 
700 0 1 |a Boros Mihály  |e aut 
700 0 1 |a Görbe Anikó  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16845/1/TubolyE_Alpha-glycerylphosphorylcholine_can_be_cytoproteortoxic.pdf  |z Dokumentum-elérés